Neuronetics rises on robust Q1 results, revenue forecast

Neuronetics

09/05/2023 18:10

** Shares of medtech firm Neuronetics Inc.  STIM.O  up about
18% at $2.59
    ** Co reports Q1 loss of 38 cents per share vs analysts'
est. of loss of 39 cents per share - Refinitiv data
    ** Q1 rev of $15.54 mln beats analysts' est. of $15.18 mln
    ** Co sees Q2 total worldwide rev between $17 mln-$18 mln,
mid-point above analysts' est. of $17.3 mln
    ** Co also expects FY total worldwide rev between $68 mln-
$73 mln, mid-point of which is above analysts' est. of $68.99
mln
    ** STIM stock down 62.59% YTD

 (Reporting by Rupali Chaudhary in Bengaluru)
 ((Rupali.chaudhary@thomsonreuters.com))